Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection

Sci Rep. 2015 Sep 3;5:12769. doi: 10.1038/srep12769.


Decoy receptor 3 (DcR3) expression in kidneys has been shown to predict progression of chronic kidney disease. We prospectively investigated a cohort comprising 96 renal transplant recipients (RTRs) undergoing graft kidney biopsies. Computer-assisted quantitative immunohistochemical staining value of DcR3 in renal tubular epithelial cells (RTECs) was used to determine the predictive role of DcR3 in kidney disease progression. The primary end point was doubling of serum creatinine and/or graft failure. A multivariate Cox proportional hazards model was used to assess the risk of DcR3 expression in rejected kidney grafts toward the renal end point. In total, RTRs with kidney allograft rejection were evaluated and the median follow-up was 30.9 months. The greater expression of DcR3 immunoreactivity in RTECs was correlated with a higher rate of the histopathological concordance of acute T cell-mediated rejection. Compared with 65 non-progressors, 31 progressors had higher DcR3 expression (HDE) regardless of the traditional risk factors. Cox regression analysis showed HDE was significantly associated with the risk of renal end point with a hazard ratio of 3.19 (95% confidence interval, 1.40 to 7.27; P = 0.006) after adjusting for other variables. In repetitive biopsies, HDE in tissue showed rapid kidney disease progression due to persistent inflammation.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • Comorbidity
  • Female
  • Graft Rejection / metabolism*
  • Graft Rejection / mortality*
  • Graft Survival
  • Humans
  • Kidney / metabolism
  • Kidney Failure, Chronic / metabolism*
  • Kidney Failure, Chronic / mortality*
  • Kidney Failure, Chronic / therapy*
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Prevalence
  • Receptors, Tumor Necrosis Factor, Member 6b / metabolism*
  • Reproducibility of Results
  • Risk Factors
  • Sensitivity and Specificity
  • Survival Rate
  • Taiwan / epidemiology


  • Biomarkers
  • Receptors, Tumor Necrosis Factor, Member 6b